December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Fumiko Ladd Chino: “Guideline-concordant care” vs active monitoring in 957 patients
Dec 14, 2024, 16:35

Fumiko Ladd Chino: “Guideline-concordant care” vs active monitoring in 957 patients

Fumiko Ladd Chino, Attending in Radiation Oncology at MD Anderson Cancer Center, shared a post on X:

“SABCS24:  957 patients with low risk DCIS randomized to receive “guideline-concordant care” vs active monitoring

Key points for 2 years:

– Non inferior for dx of invasive breast Cancer (!!!)
– “Lived Experience” similar [QOL/ anxiety not worse]
– Most got ET but only 55% in GC got surgery

Primary analysis at 2 years:

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In SituThe COMET Randomized Clinical Trial

Authors: E. Shelley Hwang, Terry Hyslop, Thomas Lynch, Marc D. Ryser, Anna Weiss, Anna Wolf, Kelsey Norris, Meredith Witten, Lars Grimm, Stuart Schnitt, Sunil Badve, Rachel Factor, Elizabeth Frank, Deborah Collyar, Desiree Basila, Donna Pinto, Mark A. Watson, Robert West, Louise Davies, Jenny L. Donovan, Ayako Shimada, Yutong Li, Yan Li, Antonia V. Bennett, Shoshana Rosenberg, Jeffrey Marks, Eric Winer, Marc Boisvert, Armando Giuliano, Kelsey E. Larson, Kathleen Yost, Priscilla F. McAuliffe, Amy Krie, Nina Tamirisa, Lisa A. Carey, Alastair M. Thompson, Ann H. Partridge

Fumiko Ladd Chino: “Guideline-concordant care” vs active monitoring in 957 patients

HRQOL and Patient outcomes:

Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In SituA Secondary Analysis of the COMET Randomized Clinical Trial

Authors: Ann H. Partridge, Terry Hyslop, Shoshana M. Rosenberg, Antonia V. Bennett, Sarah Drier, Mattias Jonsson, Ayako Shimada, Yutong Li, Yan Li, Thomas Lynch, Elizabeth Frank, Deborah Collyar, Desiree Basila, Donna Pinto, Anna Weiss, Anna Wolf, Kelsey Norris, Meredith Witten, Marc Boisvert, Armando Giuliano, Kelsey E. Larson, Kathleen Yost, Priscilla F. McAuliffe, Amy Krie, Nina Tamirisa, Sonja Darai, Lisa Carey, Alastair Thompson, E. Shelley Hwang, for the COMET Study Consortium

Fumiko Ladd Chino: “Guideline-concordant care” vs active monitoring in 957 patients

Fumiko Ladd Chino is an attending in Radiation Oncology at MD Anderson Cancer Center, who specializes in gynecological and breast cancers. She was also a caregiver for her husband Andrew Mark Ladd, PhD who died from cancer in 2007.

She is a recipient of numerous awards, including ASCO Excellence in Equity Award (2022), Duke Radiation Oncology Award for Outstanding Clinical Research (2019), Duke University Hospital “Good Catch” Award (2018), Conquer Cancer Foundation of ASCO Merit Award (2018), Duke University School of Medicine Dean’s Recognition Award (2014) and Memorial Hermann Hospital, Texas Medical Center Volunteer of the Year Award (2009).